Detalles de la búsqueda
1.
Evaluating anthracycline + taxane versus taxane-based chemotherapy in older women with node-negative triple-negative breast cancer: a SEER-Medicare study.
Breast Cancer Res Treat
; 191(2): 389-399, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34705147
2.
Real-world evidence from a University Hospital system regarding the uptake of adjuvant pertuzumab and/or neratinib before and after their FDA approval.
Breast Cancer Res Treat
; 187(3): 883-891, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33625615
3.
First-in-Human Dose-Escalation Study of the Novel Oral Depsipeptide Class I-Targeting HDAC Inhibitor Bocodepsin (OKI-179) in Patients with Advanced Solid Tumors.
Cancers (Basel)
; 16(1)2023 Dec 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38201519
4.
Moving Towards Targeted Therapies for Triple-Negative Breast Cancer.
Curr Breast Cancer Rep
; 13(3): 216-226, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34457184
5.
Paraneoplastic Encephalitis Associated with Locally Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer.
J Breast Cancer
; 24(1): 106-116, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33634625
6.
Clinical Outcomes for Patients With Metastatic Breast Cancer Treated With Immunotherapy Agents in Phase I Clinical Trials.
Front Oncol
; 11: 640690, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33816286
7.
Nab-paclitaxel and atezolizumab for the treatment of PD-L1-positive, metastatic triple-negative breast cancer: review and future directions.
Expert Rev Precis Med Drug Dev
; 5(2): 59-65, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32190733
8.
Clinical outcomes of breast cancer patients treated in phase I clinical trials at University of Colorado Cancer Center.
Cancer Med
; 9(23): 8801-8808, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33063469
Resultados
1 -
8
de 8
1
Próxima >
>>